{"version":"1.0","provider_name":"Vigilant Biosciences\u00ae\u00ae sviluppa metodi avanzati e accurati per facilitare il rilevamento precoce del tumore orale identificando diversi biomarcatori unici che si sono dimostrati associati al tumore orale. Scopra come questa tecnologia salvavita pu\u00f2 fare la differenza per i suoi pazienti.","provider_url":"https:\/\/vigilantbiosciences.com\/it","author_name":"vigilantbio","author_url":"https:\/\/vigilantbiosciences.com\/it\/author\/vigilantbio\/","title":"Michael Donovan - Vigilant Biosciences\u00ae","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"UfOSCiilml\"><a href=\"https:\/\/vigilantbiosciences.com\/it\/dipl-team-member\/michael-dovan\/\">Michael Donovan<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/vigilantbiosciences.com\/it\/dipl-team-member\/michael-dovan\/embed\/#?secret=UfOSCiilml\" width=\"600\" height=\"338\" title=\"&#8220;Michael Donovan&#8221; &#8212; Vigilant Biosciences\u00ae\" data-secret=\"UfOSCiilml\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/vigilantbiosciences.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>","thumbnail_url":"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/Michael-Donovan-Headshot.jpg","thumbnail_width":720,"thumbnail_height":720,"description":"Michael Donovan Ph.D., M.D. joined Vigilant Biosciences\u00ae in 2015 and serves as the Chief Medical Officer. Dr. Donovan is board-certified in anatomic and clinical pathology and pediatric pathology with extensive experience in designing and implementing clinical studies. He has spearheaded the utilization of multiplex tissue and fluid\u2013based assays and coupled mathematical applications to produce clinically [&hellip;]"}